Skip to main content
. 2022 Apr 13;65(3):617–623. doi: 10.1007/s10840-022-01204-1

Table 3.

Analysis of additional procedure characteristics and anti-arrhythmic drug use for the subset of patients in which data were available

Esophageal protection
LET monitored (n = 75) Cooled (n = 97)
Procedure duration (min), mean (SD) 159 ± 52 113 ± 46
Fluoroscopy duration (min), mean (SD) 0.7 ± 1.6 0.6 ± 1.8
RF duration (min), mean (SD) 24 ± 9.9 21 ± 11
# of RF lesions, mean (SD) 63 ± 34 47 ± 28
Prescribed anti-arrhythmic drugs 16 (21.4%) 34 (35.6%)